Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

37.23 +0.28 (+0.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
From Harrow, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
From Harrow, Inc.
Via Business Wire
Insiders Buying Greenwich LifeSciences And 2 Other Stocks
Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades. 
Via Benzinga
Harrow: Q4 Earnings Insights
 
Via Benzinga
Earnings Preview: Harrow Health
 
Via Benzinga
Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying
 
Via Benzinga
Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying
 
Via Benzinga
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
From Melt Pharmaceuticals, Inc.
Via Business Wire
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... 
Via Benzinga
INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding. 
Via InvestorPlace
Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning. 
Via InvestorPlace
Why Is Harrow (HROW) Stock Up 5% Today?
Harrow stock is up on Wednesday as investors in HROW shares react to the company's earnings report for the fourth quarter of 2023! 
Via InvestorPlace
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning! 
Via InvestorPlace
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday. 
Via Benzinga
Topics Stocks
HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q4 2023
HROW stock results show that Harrow Health missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
From Harrow, Inc.
Via Business Wire
Earnings Scheduled For March 19, 2024
Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per share on revenue of $931.97 million. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
From Harrow, Inc.
Via Business Wire
Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
From Harrow, Inc.
Via Business Wire
Harrow Announces New Appointments to its Board of Directors
From Harrow, Inc.
Via Business Wire
Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
From Harrow, Inc.
Via Business Wire
Melt Pharmaceuticals Provides Corporate Update
From Melt Pharmaceuticals, Inc.
Via Business Wire
Harrow Partners with Leading Healthcare Market Access Technology Platforms
From Harrow, Inc.
Via Business Wire
7 Short-Squeeze Stocks That Are Screaming for Speculation
If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you. 
Via InvestorPlace
Harrow Completes Transfer of the TRIESENCE® New Drug Application
From Harrow, Inc.
Via Business Wire
Harrow to Present at Two Investor Conferences in November
From Harrow, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.